Otilia Husu
Physician Assistant · Goodyear, AZNPI 1194995951
Payments from drug & device makers
Across 145 payments — averaging $29.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Lilly USA, LLC$645
- Novo Nordisk$419
- AbbVie$286
- Abbott$181
- Inspire Medical Systems, Inc.$145
- plus $566 from 11 others
What the payments were for
- Food & beverage$4,329100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 44 | $2,087 |
| Lilly USA, LLC | 39 | $645 |
| Novo Nordisk | 15 | $419 |
| AbbVie | 15 | $286 |
| Abbott | 6 | $181 |
| Inspire Medical Systems, Inc. | 1 | $145 |
| GSK | 7 | $121 |
| Boston Scientific | 1 | $112 |
| Boehringer Ingelheim | 5 | $91 |
| Astellas Pharma US Inc | 3 | $77 |
| Exact Sciences | 2 | $36 |
| Novartis | 2 | $31 |
| Bayer | 1 | $28 |
| Nevro Corp. | 1 | $22 |
| W. L. Gore & Associates, Inc. | 1 | $19 |
| Tonix Medicines, Inc. | 1 | $14 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,329 in reported general payments places this provider in the 90th percentile of 2,888 physician assistant providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 25 | $28,295 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $18,888 |
| OzempicSemaglutide | 22 | $18,465 |
| EliquisApixaban | 17 | $16,982 |
| FarxigaDapagliflozin Propanediol | 13 | $10,304 |
| SynthroidLevothyroxine Sodium | 50 | $2,438 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 76 | $2,083 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $1,860 |
| Gabapentin | 76 | $1,506 |
| Atorvastatin Calcium | 203 | $1,349 |
| Levothyroxine Sodium | 198 | $1,308 |
| Duloxetine Hcl | 37 | $1,064 |
| Rosuvastatin Calcium | 83 | $865 |
| Doxycycline Hyclate | 84 | $763 |
| Testosterone | 19 | $687 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $645 | $28,29525 claims |
| GSKTrelegy Ellipta | $121 | $18,88822 claims |
| Novo NordiskOzempic | $419 | $18,46522 claims |
| PfizerEliquis | $14 | $16,98217 claims |
| AstraZenecaFarxiga | $2,087 | $10,30413 claims |
| AbbVieSynthroid | $286 | $2,43850 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Goodyear
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
- Alyssa BoschenPhoenix$86K
- Christopher BeroScottsdale$81K
- Katherine MinorPhoenix$76K
- Nicole StokerTucson$61K
- Micah LasleyPhoenix$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.